MAPT and Alzheimer disease: Ever since the National Institute on Aging – Alzheimer’s Association (NIA-AA) introduced a new research framework for the definition of Alzheimer’s disease (AD), fluid and imaging biomarkers of hallmark pathologies (Aβ, t-tau, p-tau) have become the main defining biomarkers in AD research.